Amalya Sargsyan, Head of Intelligence Unit at OncoDaily, Medical Oncologist at Yeolyan Hematology and Oncology Center, and Clinical Research Physician at Immune Oncology Research Institute, shared a post on LinkedIn:
“Still hard to believe, my first publication in Nature Reviews Clinical Oncology (IF 82).
Our article, ‘Advances in the management of metastatic gastric cancer: current strategies and emerging therapeutics,’ is now live.
Two years ago at the CReDO workshop, our group leader was Nature Reviews Clinical Oncology Chief Editor Diana Romero. I remember telling her:
‘One day you will see my name there.’
Today is that day.
Deeply grateful to work under the leadership of my mentor, change-maker, motivator Yelena Janjigian, led by Joan Choo, together with outstanding co-authors, Vahe Khachatryan, field leaders Sara Lonardi, Filippo Pietrantonio, Raghav Sundar MBBS, PhD, Samuel Klempner.
This review brings together the rapidly evolving landscape of metastatic gastric cancer, from current standards to what is coming next:
- Treatment sequencing.
- Immunotherapy and targeted approaches.
- Interpretation of key clinical trials.
- Future directions and new therapies.
All in one place for clinicians and researchers navigating this complex disease.
2025 has already been a transformative year for gastric cancer research. May each year bring more progress, more access, and more hope for our patients.
Motivated for what comes next.”
Title: Advances in the management of metastatic gastric cancer: current strategies and emerging therapeutics
Authors: Joan Choo, Amalya Sargsyan, Vahe Khachatryan, Sara Lonardi, Filippo Pietrantonio, Raghav Sundar, Samuel Klempner, Yelena Janjigian
Read The Full Article
Other articles about Gastric Cancer on OncoDaily.